Evidence map›Paper›PMID 41471361›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Association Between

Angel T Alvarado, Felipe L Ignacio-Cconchoy, Juan C Espinoza-Retuerto, Roxana M Contreras-Macazana, Luis Abel Quiñones, Jorge A García, María R Bendezú, Haydee Chávez, Felipe Surco-Laos, Doris Laos-Anchante and 9 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Angel T AlvaradoCenter for Research in Molecular Pharmacology and 4P Medicine, VRI, San Ignacio de Loyola University, La Molina, Lima 15024, Peru.ORCID 0000-0001-8694-8924
Felipe L Ignacio-CconchoyHuman Medicine, Faculty of Health Sciences, San Ignacio de Loyola University, La Molina, Lima 15024, Peru.ORCID 0000-0002-9360-8722
Juan C Espinoza-RetuertoHuman Medicine, Faculty of Human Medicine, José Faustino Sánchez Carrión National University, Huacho 15100, Peru.ORCID 0000-0003-1343-0483
Roxana M Contreras-MacazanaBiochemistry and Immunochemistry Department, Alberto Sabogal Sologuren National Hospital, Callao 07000, Peru.ORCID 0009-0004-2600-3020
Luis Abel QuiñonesLaboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago de Chile, Chile & Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago 8350499, Chile.ORCID 0000-0002-7967-5320
Jorge A GarcíaFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0001-9880-7344
María R BendezúFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-3053-3057
Haydee ChávezFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-8717-4307
Felipe Surco-LaosFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0003-0805-5535
Doris Laos-AnchanteFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-2454-7081
Pompeyo A Cuba-GarciaFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-0468-154X
Elizabeth J Melgar-MerinoFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-9033-8042
Bertha Pari-OlarteFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-0902-7061
Mario Bonifaz-HernándezFaculty of Pharmacy and Biochemistry, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-2834-1769
José Santiago Almeida-GalindoFaculty of Human Medicine, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-2799-2893
José Kong-ChirinosFaculty of Human Medicine, San Luis Gonzaga National University of Ica, Ica 11004, Peru.ORCID 0000-0002-8858-2353
Ricardo Pariona-LlanosGeneral Studies, FIE, National University of San Marcos, UNMSM, Lima 15081, Peru.ORCID 0000-0001-9836-6526
Priscilia Aguilar-RamírezHuman Medicine, Continental University, Los Olivos, Lima 15312, Peru.ORCID 0000-0002-4830-8720
Nelson M VarelaLaboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago de Chile, Chile & Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago 8350499, Chile.ORCID 0000-0002-5229-3007

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse drug reactionsantiseizure medicationCYP2C19CYP2C9Peruvian populationpharmacogenomics

Identifiers

PMID41471361
PMCPMC12735906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.